JNJ Johnson & Johnson
- 151.380
- +0.160+0.11%
- 151.880
- +0.500+0.33%
Johnson & Johnson News
Moody's: Gives Johnson & Johnson (JNJ.US) “Aaa” Rating to Newly Issued US Dollar and Euro Premium Unsecured Notes
On May 13, Moody's gave Johnson & Johnson (“Johnson & Johnson” JNJ.US for short) a “Aaa” rating for the newly issued US and Euro senior unsecured notes. There are no other changes to Johnson & Johnson's current ratings, including the “Aaa” Advanced Unsecured long-term rating or the “Prime-1” short-term rating outlook remaining stable.
Kenvue Prices Secondary Stock Offering as Johnson & Johnson Exits
Johnson & Johnson (JNJ.US) issued 2.5 billion euro senior bonds with coupon rates of 3.2%, 3.35%, and 3.55%, respectively
Johnson & Johnson (Johnson & Johnson for short, “Johnson & Johnson”, Moody's: Aaa Stable S&P: AAA Negative JNJ.US) issues SEC, 8-year, 12-year, 20-year senior unsecured bonds denominated in Euros. ()
Johnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)
Johnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)
Kenvue Priced Secondary Offering Of 182.3M Shares Of Common Stock At $20/Share
Kenvue Priced Secondary Offering Of 182.3M Shares Of Common Stock At $20/Share
Kenvue Announces Pricing of Secondary Offering
Kenvue Inc. (NYSE:KVUE) ("Kenvue") announced today the pricing of its previously announced secondary underwritten public offering (the "Offering") of 182,329,550 shares of its common stock (the "Shares") at a public
Is Ardagh Metal Packaging SA (NYSE:AMBP) the Best High-Dividend Penny Stock to Buy Now?
Funds Linked to Morgan Stanley, Blue Owl Join Bond Sales Blitz
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Johnson & Johnson plans to sell the remaining 10% of Kenvue's shares
GLONGHUI, May 14 | Johnson & Johnson said on Monday that it plans to sell the remaining 9.5% of its shares after Tylenol (Tylenol) manufacturer Kenvue's spin-off and listing for about a year. According to Kenvue's closing price last Friday, Johnson & Johnson involved the sale of 182.3 million shares worth about US$3.75 billion.
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
Johnson & Johnson's (NYSE:JNJ) medical device subsidiary is pulling its Megadyne Mega Soft Pediatric Patient Return Electrodes following reports of patient burns.Ethicon's Megadyne division recalled i
Top Midday Stories: Return of 'Roaring Kitty' Lifts GameStop Shares; Intel, Apollo Near Deal on Ireland Plant; BHP Latest Offer Rejected by Anglo American; Squarespace Acquired by Permira; Amazon Autonomous Driving Under Probe
The major US indexes were higher at midday Monday as investors ready themselves for a consequential inflation data release on Wednesday. In company news, shares of GameStop (GME) soared in premarket a
14 Best Long-Term Dividend Stocks To Buy Now
In this article, we discuss 14 best long-term dividend stocks to buy now.
Johnson & Johnson (JNJ) Could Be a Great Choice
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition
Johnson & Johnson (JNJ) said Monday it is offering its senior unsecured notes in four tranches to help fund its planned acquisition of Shockwave Medical (SWAV). Closing of the deal is subject to appro
Sector Update: Consumer Stocks Gain Premarket Monday
Consumer stocks were gaining premarket Monday, with the Consumer Discretionary Select Sector SPDR Fund (XLY) and the Consumer Staples Select Sector SPDR Fund (XLP) both up 0.1%. GameStop (GME) shares
Johnson & Johnson (JNJ.US) to clear Kenvue (KVUE.US) shares after one year of divestment
The Zhitong Finance App learned that Kenvue (KVUE.US) announced on Monday that Johnson & Johnson (JNJ.US) will sell all of its 9.5% shares in the company. According to information, Kenvue is a consumer health business company spun off by Johnson & Johnson and was officially listed on the New York Stock Exchange in May 2023. Based on Kenvue's recent closing price, the value of this stock sale was approximately $3.75 billion. Kenvue shares fell nearly 4% in pre-market trading.
Johnson & Johnson to Exit Kenvue in Debt-for-equity Deal
Johnson & Johnson to No Longer Own Kenvue Shares After Proposed Offering Closes
Johnson & Johnson (JNJ) is expected to exchange 182,329,550 shares of Kenvue's (KVUE) common stock for indebtedness of Johnson & Johnson to be held by Goldman Sachs and J.P. Morgan, Kenvue said Monday
We Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its Debt
Analysis
Price Target
No Data
